HOXA5 has a “dual personality” in pan-cancer: it is mostly a tumor suppressor in solid tumors, but it is transformed into a tumor promoter in blood tumors. This evidence concerns the gene HOXA5 and hematopoietic and lymphoid system neoplasm.